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Identiﬁcation of a pyrophosphate-dependent kinase
and its donor selectivity determinants
Ryuhei Nagata1, Masahiro Fujihashi1, Takaaki Sato2, Haruyuki Atomi2 & Kunio Miki1
Almost all kinases utilize ATP as their phosphate donor, while a few kinases utilize
pyrophosphate (PPi) instead. PPi-dependent kinases are often homologous to their ATP-
dependent counterparts, but determinants of their different donor speciﬁcities remain
unclear. We identify a PPi-dependent member of the ribokinase family, which differs from
known PPi-dependent kinases, and elucidate its PPi-binding mode based on the crystal
structures. Structural comparison and sequence alignment reveal ﬁve important residues:
three basic residues speciﬁcally recognizing PPi and two large hydrophobic residues
occluding a part of the ATP-binding pocket. Two of the three basic residues adapt a con-
served motif of the ribokinase family for the PPi binding. Using these ﬁve key residues as a
signature pattern, we discover additional PPi-speciﬁc members of the ribokinase family, and
thus conclude that these residues are the determinants of PPi-speciﬁc binding. Introduction of
these residues may enable transformation of ATP-dependent ribokinase family members into
PPi-dependent enzymes.
DOI: 10.1038/s41467-018-04201-z OPEN
1 Department of Chemistry, Graduate School of Science, Kyoto University, Sakyo-ku, Kyoto 606-8502, Japan. 2 Department of Synthetic Chemistry and
Biological Chemistry, Graduate School of Engineering, Kyoto University, Katsura, Nishikyo-ku, Kyoto 615-8510, Japan. Correspondence and requests for
materials should be addressed to M.F. (email: mfuji@kuchem.kyoto-u.ac.jp) or to K.M. (email: miki@kuchem.kyoto-u.ac.jp)









Kinases transfer a phosphate group from a phosphate donorto an acceptor. Various compounds are known as phos-phate acceptors (e.g., proteins, lipids, and carbohydrates),
while the donor for most kinases is ATP. A few kinases utilize
atypical donors other than ATP. One utilizes ADP as the donor1–
4, another uses inorganic pyrophosphate (PPi)5–7, and enzymes
that utilize inorganic polyphosphate are also known8,9. The
mechanism governing donor speciﬁcity and the evolutional tra-
jectory of these unique enzymes have been widely discussed but
are still unclear1,5,6,8–12.
Only three types of enzyme have been identiﬁed as PPi-
dependent kinases: PPi-dependent phosphofructokinase (PPi-
PFK), PPi-dependent pyruvate phosphate dikinase (PPi-PPDK),
and PPi-dependent acetate kinase (PPi-ACK). PPi-PFK catalyzes
the phosphorylation of D-fructose 6-phosphate using PPi to
produce D-fructose 1,6-bisphosphate, and also catalyzes the
reverse reaction11,13. PPi-PPDK catalyzes the reversible conver-
sion of phospho(enol)pyruvate, PPi, and AMP into pyruvate,
orthophosphate (Pi), and ATP13. PPi-ACK, which has been
found only in Entamoeba histolytica, catalyzes the reversible
phosphorylation of acetate with PPi as the phosphate donor.
However, PPi-ACK from E. histolytica is thought to primarily
produce PPi and acetate from Pi and acetyl phosphate under
physiological conditions because the kcat value of the PPi-
producing reaction is 1000-fold higher than that of the PPi-
consuming reaction7. The former two reactions are involved in
glycolysis/gluconeogenesis13, while PPi-ACK is presumed to
provide PPi for PPi-PFK and PPi-PPDK during glycolysis in E.
histolytica7,14.
The reason why the PPi-dependent kinases prefer PPi to ATP
as the phosphate donor remains unclear. The mechanisms of the
donor speciﬁcity in PPi-PFK and PPi-ACK have been discussed
without reference to their PPi-complex structures, but based only
on structural comparisons with their ATP-dependent homologs.
For example, the aspartate residue at the phosphate-donor-
binding site in PPi-PFK prevents the ATP binding6,15,16. In PPi-
ACK from E. histolytica, the ﬁve residues in the donor-binding
site occlude the ATP-binding cleft17,18. Thus, only mechanisms
for interfering with ATP binding have been suggested, while the
residues that speciﬁcally recognize PPi remain unclear.
Here, we identify a PPi-dependent kinase belonging to the
ribokinase family, which is distinct from the families of the pre-
viously reported PPi-dependent kinases. The crystal structure
complexed with a PPi analog reveals the PPi-binding mode of this
enzyme. Structural comparison and sequence alignment with
ATP-dependent or ADP-dependent members of the ribokinase
family reveal the importance of ﬁve residues: two large hydro-
phobic residues occluding a part of the ATP-binding pocket and
three basic residues speciﬁcally involved in PPi recognition. The
ﬁve residues are used collectively as a signature pattern and
enable us to newly identify PPi-speciﬁc members of the riboki-
nase family.
Results
Identiﬁcation of a PPi-dependent kinase. A PPi-dependent
kinase belonging to the ribokinase family was identiﬁed based on
structural similarity to a myo-inositol 3-kinase from the hyper-
thermophilic archaeon Thermococcus kodakarensis (MI3K_TK),
which is an ATP-dependent member of the ribokinase
family19,20. A Dali search21 with the substrate-complex structure
of MI3K_TK (Protein Data Bank (PDB) ID 4XF7) showed that
the structure is the most similar to the unliganded structure of
TM0415 from the hyperthermophilic bacterium Thermotoga
maritima (PDB ID 1VK4; root-mean-square (RMS) distance 2.2
Å for 254 Cα atoms out of 283 Cα atoms of TM0415; Fig. 1a).
This enzyme has been annotated as a carbohydrate kinase
belonging to the ribokinase family and is thought to be involved
in myo-inositol metabolism because its gene is located in a myo-
inositol catabolic gene cluster22,23. However, this enzyme
exhibited no ATP-dependent kinase activity toward various
carbohydrates, including myo-inositol22,23. Consistent with this
result, a part of the potential ATP-binding cleft in TM0415 is
occluded by three large residues (F221, R232, and M266; Fig. 1b).
In contrast, comparison of the acceptor-binding site between
TM0415 and MI3K_TK indicated that the ﬁve residues inter-
acting with myo-inositol in MI3K_TK are conserved in TM0415
(Fig. 1c), raising the possibility that myo-inositol is the phos-
phate acceptor of TM0415. Accordingly, the phosphate donor
speciﬁcity of TM0415 was investigated using myo-inositol as the
acceptor. This analysis demonstrated that TM0415 utilizes
PPi but neither ATP nor ADP to generate myo-inositol mono-
phosphate (Fig. 2a). Although the ribokinase family includes
various ATP-dependent or ADP-dependent kinases, including
MI3K_TK, no member has been shown to be PPi-dependent
until now.
Next, we performed kinetic analyses of TM0415 toward PPi and
myo-inositol (Supplementary Fig. 1a). The initial velocity of the
TM0415 reaction was almost constant (~17 µmol min−1 mg−1) at
a PPi concentration ranging from 15 to 500 µM. At lower
concentrations (<15 µM), the experimental signal to determine

























Fig. 1 Structural comparison between TM0415 and MI3K_TK. The structures of the unliganded TM0415 (PDB ID 1VK4) and the substrate complex of
MI3K_TK (4XF7) are shown in pink and green, respectively. a Superposition of the Cα traces of the overall structures. b,c Comparison of the phosphate-
donor- or acceptor-binding site. Green dotted lines represent the interactions between myo-inositol and the residues in MI3K_TK. The ligands and residues
in the ligand-binding site are shown as sticks
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results, the values of Km and kcat toward PPi were estimated to be
<15 µM and ~9.5 s−1, respectively. The estimated Km value is
comparable to those of previously reported PPi-dependent kinases
(1.2–200 µM)6,7,12,24–30. On the other hand, the values of Km and
kcat toward myo-inositol are 12 ± 2mM and 10.8 ± 0.3 s−1,
respectively. The Km value is 40 times higher than that of
MI3K_TK (0.30 ± 0.03 mM)19. This raises the possibility that the
genuine phosphate acceptor of TM0415 is a compound other
than myo-inositol: for example, compounds related with the myo-
inositol metabolic pathway that is composed of enzymes encoded
by the TM0411–TM0416 operon in T. maritima, such as 2-keto-
myo-inositol, diketo-inositol, 5-keto-L-gluconate, and D-tagatur-
onate (Supplementary Fig. 1b)23. These compounds have many
hydroxyl and carbonyl groups, and thus possibly make hydrogen
bonds with residues in the acceptor-binding site of TM0415. The
kcat value toward myo-inositol is approximately the same as that
toward PPi, verifying that the kinetic analyses of the two
substrates were carried out accurately.
The effect of a potassium ion on the TM0415 activity was
investigated because the activation of some ribokinase family
enzymes by monovalent cations has been reported31–33. However,
activation of the TM0415 reaction was not observed while adding
KCl up to 100 mM (Supplementary Fig. 1a). The lack of
activation of TM0415 by the monovalent cation is consistent
with one of its structural features. That is, structural comparison
between TM0415 and ribokinase from Escherichia coli (RK_EC,
PDB ID 1GQT), which is activated by potassium or cesium
ions31, showed that the amino group of K265 in TM0415
occupies the position of the monovalent cation in RK_EC
(Supplementary Fig. 2). MI3K_TK, which is not activated by the
potassium ion, also possesses R252, which occupies the
corresponding position20. The presence of these positive residues
probably prevents the monovalent cations from binding and
results in the insensitivity of TM0415 to the monovalent cations.
Phosphate-donor recognition. In order to elucidate the PPi-
binding mode of TM0415, we determined its crystal structure
complexed with a PPi analog (methylenediphosphonic acid:
PCP), which has a carbon atom instead of an oxygen atom in the
bridge position of PPi. In an asymmetric unit, two protein
molecules were found: chains A and B (Supplementary Fig. 3a).
The dimer structure probably does not reﬂect the physiological
form of the protein, because size exclusion chromatography
showed that TM0415 is a monomeric protein in solution (Sup-
plementary Fig. 3b). Chain A was complexed with PCP, a mag-
nesium ion, and myo-inositol, while chain B possessed a sulfate
ion, which is derived from a crystallization precipitant, instead of
PCP without any magnesium ions (Supplementary Fig. 3a,c). The
structures of chains A and B were very similar to each other (RMS
distance 0.6 Å for 274 Cα atoms out of 275 chain B Cα atoms) and
also similar to the unliganded structure (RMS distances 0.9 Å for
274 Cα atoms and 1.0 Å for 275 Cα atoms, respectively, out of 283
Cα atoms of the unliganded structure; Supplementary Fig. 3d).
Slight differences were found only around the ligand-binding site.
In chain A, the phosphoryl group of PCP near myo-inositol
(the proximal phosphoryl group) interacts with the main-chain
nitrogen atoms of G231 and D234, while the other (the distal
phosphoryl group) is surrounded by K171, T204, and R232
(Fig. 3a). The two phosphoryl groups and four water molecules
octahedrally coordinate with the magnesium ion, which is
essential for the kinase activity (Fig. 3b). R229 is also located
near PCP, but its side chain was disordered in the structure
(Fig. 3a). We thus also determined the SO42–-complex structure,
which possesses only the sulfate ions and myo-inositol in both
molecules in an asymmetric unit. The sulfate ion is well
superimposed on the distal phosphoryl group of PCP in a
protein molecule that crystallographically corresponds to the
PCP-bound chain described above (Fig. 3a). This suggests that its
binding mode mimics the true binding mode of the distal
phosphate group of PPi because the sulfate ion has no methylene
group. This sulfate ion interacts with the side chain of R229 and
the main-chain nitrogen atom of G233 in addition to K171, T204,
and R232 (Fig. 3a). This strongly suggests that R229 and G233
recognize PPi in the reaction. The contribution of R229 to the
reaction was conﬁrmed by the fact that an R229A mutant
exhibited only 7% of the level of the wild-type activity (Fig. 3b).
The disorder of R229 in the PCP-complex structure is thought to
result from the inability of the methylene group in PCP to form
hydrogen bonds with the guanidine head of R229. The probable
PPi-binding mode is depicted in Fig. 3c.
The conservation of the residues contributing to PPi recogni-
tion (Fig. 3c) was investigated in the ribokinase family enzymes.
Sequence alignment based on structural superposition showed
that K171, R229, and R232 of TM0415 are not conserved in the
ATP-dependent and ADP-dependent members (Fig. 3d). We
then thought that it might be possible to actually predict PPi-
dependent kinases in the ribokinase family using these three
characteristic residues as a part of a signature pattern. R232 is also
one of the three large residues occluding the ATP-binding pocket,
as described above (Fig. 1b). Mutation of each characteristic
residue in TM0415 into alanine led to a drastic decrease in the
speciﬁc activity (3–11% of the wild type; Fig. 3b), conﬁrming that
the three basic residues contribute to the reaction.
Phosphate-acceptor binding. The PCP-complex structure of
TM0415 also revealed that its myo-inositol-binding mode is dif-
ferent from that of MI3K_TK, although the residues interacting
with myo-inositol in MI3K_TK are conserved in TM0415
(Fig. 1c). D11, N78, Q141, and R145 in TM0415 interact with
four of the six hydroxyl groups in myo-inositol (Fig. 4a), whereas
D12, G26, Q136, R140, and D219 in MI3K_TK interact with all
six hydroxyl groups (Fig. 4b)19. As shown in Fig. 4c, structural
superposition of the two enzymes showed that the six-membered
ring of myo-inositol tilts 30–40° and rotates ~120° from each
other. One of the possible reasons for this shift is the difference of













Fig. 2 Analyses of the phosphate donor and the product. LC-MS analyses
on the myo-inositol monophosphate produced from the reactions with
TM0415 (a), homolog No. 7 (b), and homolog No. 49 (c). Ins(1)P and Ins
(3)P represent the authentic compounds, and “No” means that the reaction
was performed without phosphate donors. Eluted myo-inositol
monophosphate was detected by MS with a mass range of m/z
259.0211–259.0237
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namely, L77, L87, and V112 in MI3K_TK are replaced with N78,
S89, and L116 in TM0415, respectively (Fig. 4a,b).
The difference of the binding mode led to a difference of the
phosphorylated position of the produced myo-inositol mono-
phosphate. In the TM0415 structure, the probable catalytic
residue D234 and the proximal phosphoryl group of PCP are
nearest to the 1-hydroxyl group of myo-inositol (3.7 and 3.4 Å,
respectively, Fig. 4a). In addition, HPLC analysis using a chiral
column showed that the elution time of the TM0415 product
coincided with that of 1D-myo-inositol 1-phosphate (Ins(1)P)
but not that of 1D-myo-inositol 3-phosphate (Ins(3)P), which is
the product of MI3K_TK19 (Fig. 2a). The structural and
chromatographic analyses led us to conclude that TM0415
phosphorylates the 1-hydroxyl group of myo-inositol and
produces Ins(1)P.
Seeking unidentiﬁed PPi-dependent kinases. The three basic
residues recognizing PPi (K171, R229, and R232; Fig. 3a,c) and
the two large hydrophobic residues occluding the ATP-binding
pocket (F221 and M266, which together with one of the three
basic residues, R232, are the three large residues shown in Fig. 1b)
in TM0415 are expected to be the key residues for discovering
various unidentiﬁed PPi-dependent kinases from the ribokinase
family. An initial BLAST search using the overall
TM0415 sequence as the query found only 24 homologs pos-
sessing the ﬁve key residues. The hit numbers were increased to
52 homologs by submitting the PPi-binding domain (residues
169–286) of TM0415 as the query sequence. In general, the
overall structure of the ribokinase family enzymes is divided into
two domains: the phosphate-acceptor-binding domain (the N-
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Fig. 3 PPi recognition in TM0415. a The PPi-binding sites of the PCP complex (left, cyan) and the SO42– complex (right, yellow) of TM0415. Superposition
of the two complexes is shown in a center panel. Dotted lines represent the interactions involving PCP, the sulfate ion, and the magnesium ion. The three
panels are drawn from the same viewpoint. b Speciﬁc activities of TM0415 (wild-type and its mutants). WT, wild-type; WT+ EDTA, wild-type in the
presence of 1 mM EDTA. ND means no detectable activity. Activity measurements were performed in triplicate, and standard deviations are represented as
error bars. c A schematic diagram depicting the probable PPi-recognition mode. Gray dotted lines show the interactions involving PPi (magenta) and the
magnesium ion. d Sequence alignment of the ribokinase family enzymes based on 3D-structure superpositions. The sequences around the GXGD motif in
AGK_PF and AGK_TL are displayed in a green box under the alignment, because the order of the secondary structures around the GXGD motif in the two
AGKs is different from those in the other enzymes, although the regions around the motif are superimposable in 3D-structure. Details are explained in
Supplementary Fig. 7. Red circles indicate the residues interacting with PPi in panel c. Yellow bars highlight the characteristic residues of TM0415 (K171,
R229, and R232) and the corresponding residues. Green and blue triangles indicate the NXXE motif and GXGD motif, respectively. Abbreviations of the
ribokinase family enzymes are shown in Supplementary Table 7
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half; Supplementary Fig. 3e). The increase in the hit number may
result from elimination of the noise from the acceptor-binding
domain in the BLAST search. Among the 52 homologs, two were
TM0415 itself, and the other 50 homologs were presumed as
candidate PPi-dependent kinases. Twenty of the candidate PPi-
dependent kinases displayed no signiﬁcant difference in the
acceptor-binding site compared to TM0415 (Supplementary
Fig. 4; Supplementary Table 1), suggesting that their phosphate
acceptors are the same as that of TM0415. The other 32 homologs
exhibited differences in the acceptor-binding site (Supplementary
Table 2), raising the possibility that their acceptors are different
from that of TM0415.
In order to examine whether the candidate PPi-dependent
kinases exhibit PPi-speciﬁc kinase activity, recombinant proteins
of ﬁve homologs (Nos. 7, 48, 49, 92, and 111) among the 32
homologs in Supplementary Table 2 were prepared by hetero-
logous expression in E. coli. There were some differences in the
sequences of the acceptor-binding sites among the ﬁve homologs.
The expression of homolog No. 92 was poor (Supplementary
Fig. 5a), and thus the activities of the other four homologs were
investigated. Fourteen candidates for acceptors were tested:
pentose (D-ribose and D-xylose), hexose (D-fructose and D-
glucose), amino sugar (D-glucosamine), sugar alcohol (glycerol,
meso-erythritol, and myo-inositol), disaccharide (sucrose and
maltose), nucleoside (inosine, adenosine, and cytidine), and 2-
keto-3-deoxygluconate. The activities were assayed using mala-
chite green, which allows photometric determination of the Pi
concentrations. The assay showed that homolog No. 49, in
addition to TM0415, produced Pi upon incubation with PPi and
myo-inositol (Supplementary Fig. 5b). In contrast, low levels of
Pi production were observed with homolog No. 7 under the same
conditions, and no activity was observed with the other two
homologs, Nos. 48 and 111, at least with the phosphate acceptors
examined here (Supplementary Fig. 5b). We further carried out
incubation for longer periods of time with these three homologs,
and an apparent production of Pi by homolog No. 7 was
observed when myo-inositol was used as the acceptor (Supple-
mentary Fig. 5c). No signiﬁcant activity of the other two
homologs was detected even with overnight (17 h) incubation
(Supplementary Fig. 5c). LC-MS analysis conﬁrmed that
homologs No. 7 and 49 produce myo-inositol monophosphate,
utilizing PPi but not ATP or ADP (Fig. 2b,c), strongly suggesting
that these two homologs are PPi-dependent kinases. We presume
that the absence of activities in homologs No. 48 and 111 may
simply be due to the fact that the proteins mainly recognize
phosphate acceptors that differ from those applied in our
experiments. The fact that two of the examined proteins actually
exhibited PPi-dependent activity suggests that the ﬁve residues
(K171, F221, R229, R232, and M266) in the donor-binding site
can be used as signatures to predict and discover unidentiﬁed
PPi-dependent kinases. Identiﬁcation of the true substrates of
homologs No. 48 and 111 and conﬁrmation of PPi-dependent
activity should greatly strengthen our proposal.
LC-MS analysis also provided insight into the phosphorylated
position of the produced myo-inositol monophosphate by the
homologs. The results clearly showed that the product of
homolog No. 7 is not Ins(1)P (Fig. 2b). This change of product
may arise from the replacement of I76 and S89 in TM0415 with
cysteine and glutamine, respectively, in the acceptor-binding site
(Supplementary Table 2). Homolog No. 49 seemed to produce
three distinct myo-inositol monophosphates that exclude Ins(1)P
(Fig. 2c). The product change may result from the replacement of
N78, S89, and L116 in TM0415 with leucine, leucine, and serine,
respectively, in the acceptor-binding site (Supplementary Table 2).
The product diversity probably resulted from the ambiguous
acceptor recognition. The non-speciﬁc recognition implies that
the genuine acceptor of homolog No. 49 is a compound other
than myo-inositol.
Discussion
We discovered a PPi-dependent member of the ribokinase family,
TM0415, and structurally elucidated the reason why the enzyme
prefers PPi to ATP as the phosphate donor. The structural
comparison between TM0415 and MI3K_TK showed that F221,
R232, and M266 in TM0415 occupy a part of the ATP-binding
cleft (Fig. 1b), suggesting that these three large residues prevent
ATP from binding. The determined structures of TM0415
revealed the residues contributing to PPi binding (Fig. 3a,c).
Three of them (K171, R229, and R232) are characteristic of
TM0415 in the ribokinase family (Fig. 3d), and R232 is note-
worthy for its contribution to both hindering ATP binding and
interacting with PPi. The identiﬁcation of characteristic residues
of PPi recognition in PPi-dependent kinases has not been
reported until now. In PPi-PFK and PPi-ACK, the PPi-
recognition mode is unclear, and only residues obstructing ATP
binding have been reported so far. In PPi-PFK, the conserved
aspartate residue (e.g., D175 in the enzyme from E. histolytica) is
suggested to prevent ATP binding, because its replacement with








































Fig. 4 myo-inositol-binding mode. a,b The myo-inositol-binding sites in the PCP-complex of TM0415 (cyan) and the substrate complex of MI3K_TK (green,
PDB ID 4XF719). Dotted lines represent the interactions between myo-inositol and the residues. The two panels are drawn from the same viewpoint. c
Structural superposition of the two myo-inositol molecules bound to TM0415 (light orange) and MI3K_TK (pale blue). Double-headed arrows indicate the
rotation of myo-inositol. The two panels are drawn from two different viewpoints. The atom numbering of myo-inositol carbons is shown in the same color
in panels a and b
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Km value toward ATP6. In PPi-ACK from E. histolytica, the ﬁve
residues (T201, D322, Q323, M324, and E327) occlude the ATP-
binding cleft of ATP-ACK17,18. These residues were introduced to
ATP-dependent kinases in order to transform them into PPi-
dependent ones, but these attempts were unsuccessful6,17,18. Our
identiﬁcation of the three basic residues of TM0415 may enable
such transformation on ATP-dependent ribokinase family mem-
bers, which phosphorylate various acceptors. This engineering will
reduce costs for the production of a variety of phosphorylated
compounds, because PPi is 1000-fold cheaper than ATP.
TM0415 and the 50-candidate PPi-dependent kinases may be
members of a PPi-dependent group of the ribokinase family,
which is the third subclass of this family in addition to those of
the ATP-dependent and ADP-dependent enzymes. This is a
unique example of a kinase family that contains ATP-, ADP-, and
PPi-dependent enzymes. Thirty-two of the ﬁfty enzymes exhib-
ited some differences in the acceptor-binding site when compared
to TM0415 (Supplementary Table 2). Two of them, homologs No.
7 and 49, phosphorylate myo-inositol utilizing PPi in the manner
of TM0415, but the phosphorylated hydroxyl group is different
from that of TM0415 (Fig. 2b,c). This change may result from the
different binding orientation of the acceptor caused by substitu-
tions in the acceptor-binding site. The other homologs in Sup-
plementary Table 2 also display various substitutions in the
acceptor-binding site, and thus the PPi-dependent kinases in the
ribokinase family possibly include a variety of enzymes exhibiting
different acceptor speciﬁcity.
Among the homologs examined in this study, homolog No. 49,
which exhibited PPi-dependent kinase activity but no activity
with ATP/ADP, is from Levilinea saccharolytica, a member of the
phylum Chloroﬂexi in bacteria. Homolog No. 7, from Acantha-
moeba castellanii, is a eukaryotic enzyme that also displayed
activity with PPi. This suggests that the PPi-dependent ribokinase
family members are not conﬁned to the Thermotogae or bacteria.
The source organisms of the 50-candidate PPi-dependent kinases
are members of diverse bacterial phyla (e.g., Thermotogae, Pro-
teobacteria, Spirochetes, and Chloroﬂexi) and three were from
eukaryotic organisms, suggesting that the PPi-dependent riboki-
nase family enzymes may be widely distributed in nature.
R229 and R232 of the three basic residues in TM0415 are
located around the GXGD motif. R229 is positioned two residues
before the motif, and R232 corresponds to the second residue in
the motif (Fig. 3d). This motif is conserved in the ribokinase
family enzymes33,34. The aspartate residue is the catalytic residue,
and the two glycine residues recognize the phosphate groups of
the phosphate donor. The second residue is a small one (Ala, Cys,
Val, Ser, or Thr) in ATP-dependent members to make room for
the adenine and ribose groups of the nucleotide (Fig. 3d). In the
ADP-dependent members, the residue is replaced with Ile or Leu
to ﬁll the small space created by the size difference between ADP
and ATP. In the PPi-dependent kinase TM0415, the large residue
R232 is situated in the corresponding position in order to
recognize a smaller phosphate donor molecule. In addition, the
two arginine residues are conserved in the 50-candidate PPi-
dependent kinases (Supplementary Table 1, 2). Therefore, we
propose an RXGRGD motif (the residues GRGD correspond to
the GXGD motif) for the PPi-dependent kinases belonging to the
ribokinase family.
The ribokinase family enzymes also possess an NXXE motif
near the phosphate-donor-binding site, which is involved in
magnesium binding33,35. In the PCP-complex structure, the
magnesium-coordinated waters are surrounded by D139, D173,
and E176 (Fig. 3a). The latter two residues correspond to the ﬁrst
and last residues of the NXXE motif. The asparagine residue in
the motif is replaced with aspartic acid in TM0415. This sub-
stitution is also observed in some ATP-dependent enzymes in the
ribokinase family (Fig. 3d). Thus, the substitution of Asp for Asn
in the NXXE motif may be unrelated to the speciﬁcity toward PPi.
As already described, three kinds of PPi-dependent kinases
(PPi-PFK, PPi-PPDK, and PPi-ACK) have been identiﬁed thus
far. We investigated whether the RXGRGD motif and/or the ﬁve
key residues for the PPi-dependent members of the ribokinase
family are found in the three kinds of enzymes. No signature
patterns corresponding to the motif and the key residues were
observed in PPi-PPDK and PPi-ACK. In the phosphate-donor-
binding site of PPi-PFK, two basic residues were found (e.g., K148
and H384 in PPi-PFK from Borrelia burgdorferi), which are not
conserved in ATP-PFK. However, their contributions to PPi binding
remain to be elucidated. Further investigations including determi-
nation of the PPi-complex structure are necessary for identifying
signature patterns for the three kinds of PPi-dependent kinases.
The evolutional trajectory of the PPi-dependent kinases is a
controversial topic. For example, three hypotheses of the evolu-
tional relationship between PPi-PFK and ATP-PFK have been
proposed: PPi-PFK evolved into or from ATP-PFK5,6,11 or
emerged from a common ancestor independently of ATP-PFK36.
In the ribokinase family, the evolutional trace has been discussed
based on the size of the lid domain37, which covers the ligand-
binding site. A kinase without a lid domain is thought to be the
ancient type of kinase. All kinases without the lid domain are
ATP-dependent, suggesting that this ribokinase family originated
from an ATP-dependent enzyme without a lid. As the enzyme
evolved, the lid domain occurred and became larger to protect its
substrates from the solvent (Supplementary Fig. 6a). The size of
the lid varies widely, ranging from those consisting of only loops
(smallest) to those with ﬁve strands and four helices (largest). All
reported ADP-dependent ribokinases harbor the largest lid
domain1, and are thus considered to have evolved from ATP-
dependent enzymes with large, but slightly smaller lids with ﬁve
strands and two helices (Supplementary Fig. 6a). TM0415 pos-
sesses a medium-sized lid domain with four β strands
(Supplementary Fig. 6a). According to the hypothesis stated
above, TM0415 is not at the root of the evolutional tree of the
ribokinase family enzymes. Primary sequences suggest that lid
domains of similar size are found in most of the 50-candidate
PPi-dependent kinases (Supplementary Fig. 6b). It should be
noted that the relationship between PPi dependency and lid size
is free from any query sequence bias. The query was composed of
only the phosphate-donor-binding domain (the C-terminal half),
whereas the lid domain is positioned in the N-terminal half. The
conserved medium-sized lid domain implies that the PPi-
dependent members of the ribokinase family emerged from the
ancient ATP-dependent enzymes during the evolutional process.
Methods
Plasmid preparation. Enzymes selected for activity measurements were prepared
as N-terminal His-tag fusion proteins, while those for crystallization were produced
without a His-tag. The TM0415 gene was synthesized to produce a His-tag fusion
protein (Supplementary Table 3) and inserted into the NcoI site of pET-15b by
GenScript. The plasmids for expressing its mutants (K171A, R229A, and R232A)
were prepared by inverse PCR using the TM0415 plasmid and the oligonucleotides
K171A-F4, K171A-R4, R229A-F, R229A-R, R232A-F, and R232A-R (Supplemen-
tary Table 4) as a template and primers, respectively. In preparation of the enzymes
for crystallization, the oligonucleotides (tag-rm-F and tag-rm-R; Supplementary
Table 4) were used as primers for inverse PCR in order to remove the His-tag. The
genes of the TM0415 homologs (No. 7, 48, 49, 92, and 111) were synthesized by
GENEWIZ (Supplementary Table 5) and inserted into the NdeI and BamHI sites of
the pCold II vector. The sequences of the resultant plasmids were conﬁrmed by
DNA sequencing (Hokkaido System Science or Macrogen Japan).
Protein expression and puriﬁcation. E. coli strain BL21(DE3)pLysS (Novagen)
cells were transformed with the plasmids described above. The transformants were
cultured at 37 °C in lysogeny broth medium containing 100 µg/mL ampicillin and
100 µg/mL chloramphenicol. For gene expression using the pET-15b vector, iso-
propyl-β-D-1-thiogalactopyranoside (IPTG) was added (ﬁnal concentration 0.2
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mM) at a cell density of 0.4 (optical density at 600 nm) to induce gene expression.
After a further culture for 4 h, the cells were harvested by centrifugation (5,000×g
for 15 min at 4 °C). In the expression with pCold II vector, the medium was cooled
on ice for 30 min before the addition of IPTG. After the addition of IPTG and a
further culture at 15 °C for 24 h, the cells were harvested by centrifugation.
The His-tagged TM0415 enzymes for the analysis of phosphate donor
speciﬁcity were puriﬁed by Ni afﬁnity chromatography. Cells were resuspended in
buffer A (20 mM Tris-HCl (pH 7.4), 150 mM NaCl, 0.25 mM Tris(2-carboxyethyl)
phosphine hydrochloride (TCEP-HCl)) containing an EDTA-free protease
inhibitor cocktail (Nacalai Tesque) and disrupted by sonication. The sonicate was
centrifuged (20,000×g for 30 min at 4 °C), and imidazole-HCl (pH 7.4) was added
(ﬁnal concentration 10 mM) into the supernatant. The supernatant was then mixed
with Ni-NTA Superﬂow resin (QIAGEN) for 30–45 min at room temperature
(RT). This mixture was loaded onto the column, and the ﬂow-through fraction was
collected. The resin was washed with buffer A supplemented with 50 mM
imidazole-HCl (pH 7.4) for three column volumes (CVs), and the sample was
eluted by buffer A supplemented with 300 mM imidazole-HCl (pH 7.4) for three
CVs. The buffer of the eluate was exchanged with buffer A by ultraﬁltration with an
Amicon Ultra centrifugal ﬁlter unit (molecular weight cut off 10,000; Millipore).
The His-tagged TM0415 enzymes for kinetic analysis were puriﬁed by Ni
afﬁnity, anion exchange, and size exclusion chromatography. Cells were
resuspended in buffer B (50 mM Tris-HCl (pH 7.9), 50 mM NaCl, 1 mM MgCl2,
0.25 mM TCEP-HCl) and disrupted by sonication. The sonicate was centrifuged,
and imidazole-HCl (pH 7.9) was added (ﬁnal concentration 10 mM) into the
supernatant. Afﬁnity chromatography was performed as described above using the
following buffers: wash buffer (50 mM potassium phosphate buffer (pH 7.8), 40
mM imidazole-HCl (pH 7.9), 300 mM NaCl, 10% (v/v) glycerol, 0.25 mM TCEP-
HCl) and elution buffer (20 mM Tris-HCl (pH 7.9), 300 mM imidazole-HCl (pH
7.9), 10% (v/v) glycerol, 0.25 mM TCEP). The buffer of the eluted fractions was
exchanged with buffer C (20 mM Tris-HCl (pH 8.1), 0.25 mM TCEP-HCl) by
ultraﬁltration. The sample was applied to a 1 mL MonoQ anion exchange column
(GE Healthcare) equilibrated with buffer C and eluted with a linear gradient of
0–250 mM NaCl within 10 CVs. The eluted fractions at NaCl concentrations of
30–80 mM were concentrated by ultraﬁltration. The sample was applied to a
Superdex 200 Increase size exclusion column (GE Healthcare) equilibrated with
buffer C supplemented with 150 mM NaCl and separated with the same buffer. The
buffer of the relevant fractions was exchanged with 50 mM MES-NaOH (pH 6.1)
for kinetic analysis.
Puriﬁcation of the non-tagged TM0415 for crystallization was performed by
heat treatment, anion exchange, and size exclusion chromatography. Cells were
resuspended in buffer B supplemented with 10 mM MgCl2 and disrupted by
sonication. The sonicate was heat-treated at 80 °C for 15 min and centrifuged. In
order to remove nucleic acid, the supernatant was treated with ~130 µg/mL
deoxyribonuclease I from bovine pancreas (Sigma-Aldrich) and ~13 µg/mL
ribonuclease A from bovine pancreas (Nacalai Tesque) for 90 min at RT. The
buffer of this sample was exchanged with buffer C. The sample was further puriﬁed
by anion exchange and size exclusion chromatography as described for the kinetic
analysis, except that the eluted sample of the size exclusion column was just
concentrated for crystallization.
TM0415 for acceptor screening was puriﬁed by Ni afﬁnity chromatography
alone. Cells were resuspended in buffer B and disrupted by sonication. The
suspension was centrifuged, and the supernatant was puriﬁed by afﬁnity
chromatography. The chromatography was performed using the procedures
applied for the puriﬁcation of enzymes for kinetic analysis as described above. The
buffer of the eluted samples of the afﬁnity column was exchanged with buffer D
(50 mM Tris-HCl (pH 7.9), 100 mM NaCl, 0.25 mM TCEP-HCl).
The homolog proteins were puriﬁed in the same way as TM0415 used for the
acceptor screening, but disruption was performed by BugBuster Protein Extract
Reagent (Novagen). After puriﬁcation with the Ni-NTA column, the buffer of the
sample was exchanged with buffer D or 100 mM ammonium acetate buffer (pH
6.6) by ultraﬁltration for the acceptor screening or LC-MS analysis of the donor
speciﬁcity, respectively.
Acceptor screening of the TM0415 homologs. Acceptor screening of homologs
No. 7, 48, 49, and 111 was performed by the malachite green assay. The enzymatic
reaction mixture (100 µL) was composed of 0.2 µg enzyme (TM0415 or its
homologs), 350 or 7 mM phosphate acceptor, 500 µM PPi, 500 µM MgCl2, 100 mM
KCl, 100 mM NaCl, 0.25 mM TCEP-HCl, and 50 mM Tris-HCl (pH 7.9). The
following phosphate acceptors were tested: D-ribose, D-xylose, D-fructose, D-glu-
cose, D-glucosamine, glycerol, meso-erythritol, myo-inositol, sucrose, maltose,
inosine, adenosine, cytidine, and 2-keto-3-deoxygluconate (the former 10 com-
pounds were used at 350 mM and the others at 7 mM). These compounds were the
representative acceptors of the ribokinase family enzymes except for the com-
pounds affecting the malachite green coloring. After preincubation at 37 °C (or 70 °
C for TM0415) for 3 min, the enzymatic reaction was initiated by adding PPi. The
reaction was carried out for 10 min, 8 h, or 17 h and was terminated by cooling on
ice for 5 min. An aliquot (50 µL) of the reaction mixture was blended with 100 µL
of the BIOMOL GREEN reagent (Enzo Life Science) and incubated at RT for 20
min. The coloration was checked visually.
LC-MS analysis on donor speciﬁcity and products. Conﬁrmation of the activities
and analyses of the phosphate-donor speciﬁcities were performed by LC-MS. The
reaction mixture with TM0415 (100 µL) was composed of 5 µg TM0415, 6 mM
myo-inositol, 5 mM phosphate donor (ATP, ADP, or PPi), 10 mM MgCl2, and 100
mM ammonium acetate buffer (pH 6.65). The reaction was carried out for 5 min at
85 °C. For the homologs, the reaction mixture (100 µL) was composed of 3 µg
enzyme (homolog Nos. 7 and 49), 50 mM myo-inositol, 500 µM PPi, 500 µM
MgCl2, and 100 mM ammonium acetate buffer (pH 6.6). The reaction was per-
formed for 17 h for 37 °C. The enzymes in the mixtures were removed by ultra-
ﬁltration, and the ﬁltrate was analyzed by LC-MS. The methods used for the LC-
MS analysis were reported previously19. Authentic Ins(1)P and Ins(3)P were
purchased from Cayman Chemical Company.
Kinetic analysis of TM0415. Kinetic analysis of TM0415 was performed by
detecting the produced Pi using a malachite green assay. The enzymatic reaction
mixture (100 µL) was composed of 27 ng His-tagged TM0415, 15–500 µM PPi,
2–200 mM myo-inositol, 500 µM MgCl2, and 50 mM MES-NaOH (pH 6.1). After
preincubation at 70 °C for 3 min, the kinase reaction was initiated by adding PPi.
The reaction was carried out at 70 °C for 1, 2, or 3 min and terminated by cooling
on ice for 5 min. An aliquot (50 µL) of the reaction mixture was blended with 100
µL of the BIOMOL GREEN reagent and incubated at RT for 20 min. The absor-
bance of the mixture at 620 nm was measured using a V-630 spectrophotometer
(JASCO Corporation). The amount of Pi produced in the kinase reaction was
calculated from the absorbance based on the calibration curve. The kinetic para-
meters were determined using the program SigmaPlot (HULINKS Inc.).
Speciﬁc activities of the TM0415 mutants (K171A, R229A, and R232A) and
wild type were also measured with the malachite green assay. The enzymatic
reaction mixture (100 µL) was composed of 0.02–1 µg His-tagged enzymes, 500 µM
PPi, 200 mM myo-inositol, 500 µM MgCl2, and 50 mM MES-NaOH (pH 6.1). In
these conditions, the enzymes seemed to exhibit Vmax from preliminary analysis. In
analysis of the magnesium dependence, the mixture contained 1 mM EDTA
instead of MgCl2. The further procedure is the same as that of kinetic analysis
described above.
Crystallization and structure determination. Crystallization was performed with
the sitting-drop vapor diffusion method. The protein solution was composed of 10
mg/mL TM0415 (no His-tag, puriﬁed for crystallization), 500 mM myo-inositol, 10
mM PCP, 10 mM MgCl2, 150 mM NaCl, 0.25 mM TCEP-HCl, and 20 mM Tris-
HCl (pH 8.1). The solution was incubated at RT for 1 h and centrifuged (15,400×g
for 5 min at RT) in order to remove the salt precipitate of PCP and magnesium.
The supernatant was blended with an equal amount of the precipitant solution
composed of 21–29% (w/v) poly(ethylene glycol) 4000, 2 or 20 mM ammonium
sulfate (A/S), and 100 mM sodium acetate buffer (pH 4.6), and then equilibrated at
20 °C. The precipitant including 2 or 20 mMA/S was used for the co-crystallization
with PCP or SO42–, respectively. The crystals were obtained within 1 month.
The crystals were soaked in cryo-protectant solution composed of 35% (w/v)
poly(ethylene glycol) 4000, 2 or 20 mMA/S, 50 mM myo-inositol, and 100 mM
sodium acetate buffer (pH 4.6) and ﬂash-frozen in a nitrogen stream at 100 K. The
concentration of A/S was the same as that of the precipitant solution of the crystals.
Diffraction data sets were collected at the beamline BL41XU of SPring-8 at a
wavelength of 1.000 Å. The data sets were integrated and scaled with the program
HKL200038. The phases were determined by the molecular replacement method
with the atomic coordinates of the unliganded TM0415 (PDB ID 1VK4) using the
program Molrep39. The structures were constructed using the program COOT40
and reﬁned using the program REFMAC541,42 with the Translation Libration
Screw reﬁnement technique. The statistics for data collections and reﬁnements are
summarized in Supplementary Table 6.
Data availability. The structural coordinates and structure factors have been
deposited in the Protein Data Bank under accession codes 5YSP (the PCP-com-
plex) and 5YSQ (the SO42–-complex). Other data are available from the corre-
sponding authors upon reasonable request.
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